{"id":68953,"date":"2019-07-29T13:35:17","date_gmt":"2019-07-29T05:35:17","guid":{"rendered":"http:\/\/facfox.com\/news\/aerospace\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital.3dm"},"modified":"2019-07-29T13:35:17","modified_gmt":"2019-07-29T05:35:17","slug":"aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital","status":"publish","type":"post","link":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/","title":{"rendered":"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital"},"content":{"rendered":"<div id=\"dpsp-content-top\" class=\"dpsp-content-wrapper dpsp-shape-rectangular dpsp-size-medium dpsp-has-spacing dpsp-has-buttons-count dpsp-show-on-mobile dpsp-button-style-1\">\n<div class=\"dpsp-total-share-wrapper\"><span class=\"dpsp-total-share-count\">124<\/span><span>shares<\/span><\/div>\n<ul class=\"dpsp-networks-btns-wrapper dpsp-networks-btns-content dpsp-networks-btns-share dpsp-column-auto\">\n<li><span class=\"dpsp-network-icon\"><\/span><span class=\"dpsp-network-label-wrapper\"><span class=\"dpsp-network-count\">14<\/span><\/span><\/li>\n<li><span class=\"dpsp-network-icon\"><\/span><span class=\"dpsp-network-label-wrapper\"><span class=\"dpsp-network-count\">106<\/span><\/span><\/li>\n<li><span class=\"dpsp-network-icon\"><\/span><span class=\"dpsp-network-label-wrapper\"><span class=\"dpsp-network-count\">4<\/span><\/span><\/li>\n<li><span class=\"dpsp-network-icon\"><\/span><span class=\"dpsp-network-label-wrapper\"><\/span><\/li>\n<\/ul>\n<\/div>\n<p id=\"yui_3_18_1_1_1467801812705_977\"> Aprecia Pharmaceuticals Company (Aprecia), is a commercial stage pharmaceutical company which develops, manufactures and markets fast melt formulations of high dose pharmaceuticals. <strong>They have announced that they have entered into an up to $30 million debt financing agreement with Hercules Capital, Inc..<\/strong> Aprecia manufactures its products using its proprietary ZipDose<sup>\u00ae<\/sup> technology platform, which utilizes  3d printing (3DP) to formulate fast melt pharmaceutical products. This process incorporates significantly higher amounts of active pharmaceutical ingredient than any other fast melt technology on the market.<\/p>\n<p id=\"yui_3_18_1_1_1467801812705_2425\">Aprecia has received initial funding of $20 million under the debt financing agreement. The proceeds will be used to purchase additional manufacturing equipment, fund the development and approval of Aprecia&#8217;s pipeline product candidates and continue to advance its ZipDose technology platform. Under the terms of the agreement, Aprecia has the option to draw up to an additional $10 million tranche upon achievement of a certain performance milestone. Armentum Partners acted as financial advisor and Morgan, Lewis &amp; Bockius LLP acted as legal advisor to Aprecia for this transaction.<\/p>\n<p id=\"yui_3_18_1_1_1467801812705_2467\"><b><br \/>\nAbout Aprecia<br \/>\n<\/b>Aprecia is a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, initially focused on epilepsy and other central nervous system disorders.  Aprecia manufactures its products using its proprietary ZipDose technology platform, which utilizes 3DP, to formulate fast melt pharmaceutical products.<\/p>\n<p>They launched their first commercial product, SPRITAM<sup>\u00ae<\/sup>, in the United States in March 2016.   SPRITAM is the only fast melt formulation of levetiracetam and the first pharmaceutical product formulated using 3DP that is approved by the U.S. Food and Drug Administration.  Aprecia is privately owned, with affiliates of Prasco, LLC and the Arington family holding a controlling interest. The company&#8217;s largest institutional investors are Deerfield Management Company and Great American Insurance Company.<\/p>\n<p>For more information visit www.aprecia.com.<\/p>\n<p id=\"yui_3_18_1_1_1467801812705_2465\"><b id=\"yui_3_18_1_1_1467801812705_2522\"><br \/>\nAbout Hercules Capital<br \/>\n<\/b>Hercules Capital, Inc. (HTGC) (&#8220;Hercules&#8221;) is a leading specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broadly diversified variety of technology, life sciences and sustainable and renewable technology industries. Since inception (December 2003), Hercules has committed more than $6.0 billion to over 350 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing.<\/p>\n<p>Companies interested in learning more about financing opportunities should contact <span class=\"__cf_email__\" data-cfemail=\"e0898e868fa088948783ce838f8d\">[email&#160;protected]<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>124shares 14 106 4 Aprecia Pharmaceuticals Company (Aprecia), is a commercial stage pharmaceutical company which develops, manufactures and markets fast melt formulations of high dose pharmaceuticals. They have announced that they have entered into an up to $30 million debt financing agreement with Hercules Capital, Inc.. Aprecia manufactures its products using its proprietary ZipDose\u00ae technology [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"close","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[53],"tags":[],"class_list":["post-68953","post","type-post","status-publish","format-standard","hentry","category-aerospace"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital - FacFox News<\/title>\n<meta name=\"description\" content=\"124shares141064 Aprecia Pharmaceuticals Company (Aprecia), is a commercial stage pharmaceutical company which develops, manufactures and markets fast melt\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital\" \/>\n<meta property=\"og:description\" content=\"124shares141064 Aprecia Pharmaceuticals Company (Aprecia), is a commercial stage pharmaceutical company which develops, manufactures and markets fast melt\" \/>\n<meta property=\"og:url\" content=\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/\" \/>\n<meta property=\"og:site_name\" content=\"FacFox News\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-29T05:35:17+00:00\" \/>\n<meta name=\"author\" content=\"edi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"edi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/\"},\"author\":{\"name\":\"edi\",\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/person\/30c6618bf20fcdd6af222ac673dfd857\"},\"headline\":\"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital\",\"datePublished\":\"2019-07-29T05:35:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/\"},\"wordCount\":390,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/facfox.com\/news\/#organization\"},\"articleSection\":[\"Aerospace\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/\",\"url\":\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/\",\"name\":\"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital - FacFox News\",\"isPartOf\":{\"@id\":\"https:\/\/facfox.com\/news\/#website\"},\"datePublished\":\"2019-07-29T05:35:17+00:00\",\"description\":\"124shares141064 Aprecia Pharmaceuticals Company (Aprecia), is a commercial stage pharmaceutical company which develops, manufactures and markets fast melt\",\"breadcrumb\":{\"@id\":\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/facfox.com\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/facfox.com\/news\/#website\",\"url\":\"https:\/\/facfox.com\/news\/\",\"name\":\"FacFox News\",\"description\":\"News and Insights of 3D Printing and Manufacturing\",\"publisher\":{\"@id\":\"https:\/\/facfox.com\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/facfox.com\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/facfox.com\/news\/#organization\",\"name\":\"FacFox News\",\"url\":\"https:\/\/facfox.com\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png\",\"contentUrl\":\"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png\",\"width\":200,\"height\":55,\"caption\":\"FacFox News\"},\"image\":{\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/person\/30c6618bf20fcdd6af222ac673dfd857\",\"name\":\"edi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g\",\"caption\":\"edi\"},\"sameAs\":[\"https:\/\/facfox.com\/news\"],\"url\":\"https:\/\/facfox.com\/news\/author\/edi\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital - FacFox News","description":"124shares141064 Aprecia Pharmaceuticals Company (Aprecia), is a commercial stage pharmaceutical company which develops, manufactures and markets fast melt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/","og_locale":"en_US","og_type":"article","og_title":"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital","og_description":"124shares141064 Aprecia Pharmaceuticals Company (Aprecia), is a commercial stage pharmaceutical company which develops, manufactures and markets fast melt","og_url":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/","og_site_name":"FacFox News","article_published_time":"2019-07-29T05:35:17+00:00","author":"edi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"edi","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/#article","isPartOf":{"@id":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/"},"author":{"name":"edi","@id":"https:\/\/facfox.com\/news\/#\/schema\/person\/30c6618bf20fcdd6af222ac673dfd857"},"headline":"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital","datePublished":"2019-07-29T05:35:17+00:00","mainEntityOfPage":{"@id":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/"},"wordCount":390,"commentCount":0,"publisher":{"@id":"https:\/\/facfox.com\/news\/#organization"},"articleSection":["Aerospace"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/","url":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/","name":"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital - FacFox News","isPartOf":{"@id":"https:\/\/facfox.com\/news\/#website"},"datePublished":"2019-07-29T05:35:17+00:00","description":"124shares141064 Aprecia Pharmaceuticals Company (Aprecia), is a commercial stage pharmaceutical company which develops, manufactures and markets fast melt","breadcrumb":{"@id":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/facfox.com\/news\/aprecia-pharmaceuticals-enters-debt-financing-agreement-with-hercules-capital\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/facfox.com\/news\/"},{"@type":"ListItem","position":2,"name":"Aprecia Pharmaceuticals Enters Debt Financing Agreement With Hercules Capital"}]},{"@type":"WebSite","@id":"https:\/\/facfox.com\/news\/#website","url":"https:\/\/facfox.com\/news\/","name":"FacFox News","description":"News and Insights of 3D Printing and Manufacturing","publisher":{"@id":"https:\/\/facfox.com\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/facfox.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/facfox.com\/news\/#organization","name":"FacFox News","url":"https:\/\/facfox.com\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/","url":"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png","contentUrl":"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png","width":200,"height":55,"caption":"FacFox News"},"image":{"@id":"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/facfox.com\/news\/#\/schema\/person\/30c6618bf20fcdd6af222ac673dfd857","name":"edi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g","caption":"edi"},"sameAs":["https:\/\/facfox.com\/news"],"url":"https:\/\/facfox.com\/news\/author\/edi\/"}]}},"_links":{"self":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts\/68953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/comments?post=68953"}],"version-history":[{"count":0,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts\/68953\/revisions"}],"wp:attachment":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/media?parent=68953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/categories?post=68953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/tags?post=68953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}